Back to Acceleration Radar
ASTHAstrana Health Inc
Consumer Discretionary · Professional Services · Small
$37.45−1.47%
As of 23 Oct 2026Mkt cap $1.9B
Stage 13
WAIT
Fundamentals
41.3/75
Technical
8.9/15
Independent
50.3/90
GCAE viewtechnical state requires waiting rather than entering now
Price
- 1M
- +8.7%
- 3M
- −1.9%
- 6M
- +11.1%
- 1Y
- +13.1%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 45.7xHist median 41.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- —
- FCF yield
- —
Quality
- ROIC
- 4.2%
- Operating margin
- 4.4%
- FCF margin
- 3.3%
- Current ratio
- 1.4x
Growth
- Revenue growth
- +56.4%Latest FY YoY
- Revenue CAGR
- +42.4%
- EPS CAGR
- −25.8%
- FCF CAGR
- +19.6%
Capital
- Share-count trend
- +2.6%3Y annualised
- Net debt
- $623M5.4x OCF
Annual trend
- CAGR 2021–2025
- +42.4%
- Latest · 2025
- $3B
- YoY
- +56.4%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
technical state requires waiting rather than entering now
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-05
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded